Cava Group Upgraded to Buy by UBS with Price Target of $90
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 10 2026
0mins
Stocks are under pressure this morning as investors confront escalating U.S.-Iran tensions and a highly anticipated inflation report. Futures are pointing lower, with the Nasdaq leading the decline as semiconductor and AI-related stocks continue to retreat from their recent highs.The market's primary focus is the May CPI report, which showed annual inflation accelerating to 4.2% in May, in line with expectations, while core monthly inflation slowed more than anticipated to 0.2%.Geopolitics are adding another layer of uncertainty. Renewed military exchanges between the United States and Iran have increased concerns about energy markets and global economic growth. Oil prices remain volatile as traders assess the risk of disruptions in the Middle East, particularly around the Strait of Hormuz.In pre-market trading, S&P 500 futures fell 0.47%, Nasdaq futures fell 0.72% and Dow futures fell 0.44%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Cava Groupup 2% after UBS upgraded the stock to Buy with a price target of $90, up from $85Hinge Healthup 1% after raising its Q2 and FY26 revenue outlook at its inaugural investor dayUP AFTER EARNINGS -Yuanbaoup 18%Cracker Barrelup 17%Core & Mainup 1%DOWN AFTER EARNINGS -Chewydown 2%J.Jilldown 8%Lakeland Industriesdown 1%LOWER -Dianthusdown 20% after peer Sanofiannounced that its riliprubart Phase 3 study in patients with chronic inflammatory demyelinating polyneuropathy will be stoppedSuper Microdown 12% after announcing a series of concurrent equity and equity-linked financing transactions totaling $7B, in expected aggregate amount as part of its plan to fund the purchase of components to satisfy the AI orders that the company has received in recent weeks for its advanced AI serversNikedown 1% after RBC Capital downgraded shares to Sector Perform with a price target of $50, down from $70
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HNGE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HNGE
Wall Street analysts forecast HNGE stock price to fall
14 Analyst Rating
14 Buy
0 Hold
0 Sell
Strong Buy
Current: 67.810
Low
59.00
Averages
64.50
High
72.00
Current: 67.810
Low
59.00
Averages
64.50
High
72.00
About HNGE
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Hinge Health Co-Founder Sells 50,000 Shares for $3.28 Million
- Sale Overview: Hinge Health co-founder Gabriel M.I. Mecklenburg sold 50,000 shares of Class A common stock for approximately $3.28 million, reflecting his utilization of available liquidity in the market.
- Ownership Structure Change: Following this transaction, Mecklenburg's direct Class A holdings dropped to zero, yet he retains substantial economic exposure with 2.97 million Class B shares, indicating significant ongoing investment in the company.
- Market Performance Context: As of June 6, 2026, Hinge Health shares closed at $63.62, with a one-year total return of 63.59%, illustrating that the sales occurred during a period of strong price appreciation.
- Financial Health Status: Hinge Health reported a 47% year-over-year increase in first-quarter sales to $182 million, with gross margins rising from 81% to 85%, and free cash flow surging from $4.2 million to $41.6 million, indicating robust performance in its rapidly growing home health business.
See More
US Stocks Decline as Chip and Airline Stocks Weigh Down Market
- Market Decline: The S&P 500 Index fell by 0.61%, the Dow Jones Industrial Average dropped by 0.88%, and the Nasdaq 100 Index decreased by 0.80%, indicating investor concerns over chipmakers and AI infrastructure stocks, which reflects a weakening confidence in technology stocks.
- Inflation Data Impact: The US May Consumer Price Index rose by 4.2% year-on-year, meeting expectations and marking the fastest increase in three years, which, while easing inflation concerns, still affects market sentiment and leads to more cautious expectations regarding future interest rate policies.
- Pressure on Airlines and Transport: Trucking companies are under pressure as Amazon expanded its LTL freight service, with Old Dominion Freight Line and FedEx Freight down over 4% and 3% respectively, indicating growing concerns about increased competition in the transportation sector.
- Energy Stocks Rise: WTI crude oil prices increased by over 1%, boosting energy producers like Devon Energy by more than 5%, suggesting that despite overall market weakness, the energy sector's profit outlook remains optimistic amid geopolitical tensions.
See More
US Stocks Decline as Inflation Data Eases Market Concerns
- Market Decline: The S&P 500 index fell by 0.28%, the Dow Jones Industrial Average dropped by 0.38%, and the Nasdaq 100 index decreased by 0.28%, indicating that weakness in technology stocks is dragging down the broader market as investors rotate out of the sector.
- Inflation Data Impact: The US May Consumer Price Index rose by 4.2% year-over-year, matching expectations and marking the fastest increase in three years, while the core CPI rose by 2.9%, also in line with forecasts, easing inflation concerns and limiting downside pressure on Treasury yields.
- Pressure on Trucking Sector: Amazon's expansion of its LTL freight service to all US destinations has led to significant declines in trucking companies, with ArcBest and Old Dominion Freight Line down over 7% and 6% respectively, reflecting market worries about the trucking industry's outlook.
- Energy Stocks Strength: WTI crude oil prices increased by more than 1%, boosting energy producers like Devon Energy, which rose over 4%, indicating that the energy sector retains resilience amid geopolitical tensions.
See More
HingeSelect Expands to Include Integrated Orthopedic Surgery
- Comprehensive Orthopedic Care: HingeSelect now encompasses physical therapy, specialist evaluations, imaging, non-surgical procedures, surgery, and post-operative recovery, delivering a complete musculoskeletal (MSK) care journey that ensures members receive appropriate treatment from the outset.
- Post-Operative Recovery Optimization: Personalized peri-surgical physical therapy, delivered both digitally and in-person, has been shown to reduce post-surgical complications by 21%, thereby enhancing patient recovery outcomes and satisfaction.
- Significant Cost Reduction: HingeSelect's network offers high-quality care at costs 30% to 50% below standard rates, effectively reducing employer expenditures on musculoskeletal care.
- Utilization Rates Decline: Compared to commercial benchmarks, HingeSelect has achieved over a 60% reduction in imaging and surgery utilization, demonstrating the effectiveness and market competitiveness of its integrated solution.
See More
Stock Market Volatility Driven by AI Fears and Trump's Iran Threats
- Market Volatility Drivers: The stock market experienced significant fluctuations on Tuesday, primarily due to heightened investor fears regarding artificial intelligence and threats from Trump concerning Iran, which led to a sharp decline in indices.
- Investor Sentiment Impact: The uncertainty surrounding future economic conditions has dampened investor sentiment, resulting in a rebound from lows but an overall weak trend, indicating a lack of confidence in economic recovery.
- Inflation Data Focus: The market is anticipating the upcoming Consumer Price Index (CPI) data release, with analysts widely expecting inflation to continue influencing monetary policy, potentially leading the Federal Reserve to adopt a more cautious stance.
- Future Outlook: Amid rapid advancements in AI technology, the market is filled with concerns regarding the prospects of related companies, prompting investors to closely monitor policy changes and global economic dynamics to adjust their investment strategies.
See More
Hinge Health Q2 2026 Revenue Forecast Exceeds Expectations
- Revenue Growth Outlook: Hinge Health expects Q2 2026 revenue between $200 million and $202 million, representing approximately 45% year-over-year growth at the midpoint, surpassing Wall Street's estimate of $194.95 million, indicating strong market demand and business expansion capabilities.
- Operating Income Forecast: The projected non-GAAP operating income for Q2 is between $50 million and $52 million, with a non-GAAP operating margin expected to be around 25% at the midpoint, reflecting effective strategies in cost control and profitability enhancement.
- Full-Year Performance Prediction: Hinge Health now anticipates full-year 2026 revenue between $818 million and $824 million, implying roughly 40% year-over-year growth at the midpoint, also exceeding the market estimate of $801.58 million, showcasing the company's sustained growth potential.
- Stock Price Reaction: Following the earnings forecast, Hinge Health shares rose 1.9% in after-hours trading, demonstrating investor confidence in the company's future growth prospects and a positive market response.
See More
Hinge Health Co-Founder Sells 50,000 Shares for $3.28 Million
- Sale Overview: Hinge Health co-founder Gabriel M.I. Mecklenburg sold 50,000 shares of Class A common stock for approximately $3.28 million, reflecting his utilization of available liquidity in the market.
- Ownership Structure Change: Following this transaction, Mecklenburg's direct Class A holdings dropped to zero, yet he retains substantial economic exposure with 2.97 million Class B shares, indicating significant ongoing investment in the company.
- Market Performance Context: As of June 6, 2026, Hinge Health shares closed at $63.62, with a one-year total return of 63.59%, illustrating that the sales occurred during a period of strong price appreciation.
- Financial Health Status: Hinge Health reported a 47% year-over-year increase in first-quarter sales to $182 million, with gross margins rising from 81% to 85%, and free cash flow surging from $4.2 million to $41.6 million, indicating robust performance in its rapidly growing home health business.
See More
US Stocks Decline as Chip and Airline Stocks Weigh Down Market
- Market Decline: The S&P 500 Index fell by 0.61%, the Dow Jones Industrial Average dropped by 0.88%, and the Nasdaq 100 Index decreased by 0.80%, indicating investor concerns over chipmakers and AI infrastructure stocks, which reflects a weakening confidence in technology stocks.
- Inflation Data Impact: The US May Consumer Price Index rose by 4.2% year-on-year, meeting expectations and marking the fastest increase in three years, which, while easing inflation concerns, still affects market sentiment and leads to more cautious expectations regarding future interest rate policies.
- Pressure on Airlines and Transport: Trucking companies are under pressure as Amazon expanded its LTL freight service, with Old Dominion Freight Line and FedEx Freight down over 4% and 3% respectively, indicating growing concerns about increased competition in the transportation sector.
- Energy Stocks Rise: WTI crude oil prices increased by over 1%, boosting energy producers like Devon Energy by more than 5%, suggesting that despite overall market weakness, the energy sector's profit outlook remains optimistic amid geopolitical tensions.
See More
US Stocks Decline as Inflation Data Eases Market Concerns
- Market Decline: The S&P 500 index fell by 0.28%, the Dow Jones Industrial Average dropped by 0.38%, and the Nasdaq 100 index decreased by 0.28%, indicating that weakness in technology stocks is dragging down the broader market as investors rotate out of the sector.
- Inflation Data Impact: The US May Consumer Price Index rose by 4.2% year-over-year, matching expectations and marking the fastest increase in three years, while the core CPI rose by 2.9%, also in line with forecasts, easing inflation concerns and limiting downside pressure on Treasury yields.
- Pressure on Trucking Sector: Amazon's expansion of its LTL freight service to all US destinations has led to significant declines in trucking companies, with ArcBest and Old Dominion Freight Line down over 7% and 6% respectively, reflecting market worries about the trucking industry's outlook.
- Energy Stocks Strength: WTI crude oil prices increased by more than 1%, boosting energy producers like Devon Energy, which rose over 4%, indicating that the energy sector retains resilience amid geopolitical tensions.
See More
HingeSelect Expands to Include Integrated Orthopedic Surgery
- Comprehensive Orthopedic Care: HingeSelect now encompasses physical therapy, specialist evaluations, imaging, non-surgical procedures, surgery, and post-operative recovery, delivering a complete musculoskeletal (MSK) care journey that ensures members receive appropriate treatment from the outset.
- Post-Operative Recovery Optimization: Personalized peri-surgical physical therapy, delivered both digitally and in-person, has been shown to reduce post-surgical complications by 21%, thereby enhancing patient recovery outcomes and satisfaction.
- Significant Cost Reduction: HingeSelect's network offers high-quality care at costs 30% to 50% below standard rates, effectively reducing employer expenditures on musculoskeletal care.
- Utilization Rates Decline: Compared to commercial benchmarks, HingeSelect has achieved over a 60% reduction in imaging and surgery utilization, demonstrating the effectiveness and market competitiveness of its integrated solution.
See More
Stock Market Volatility Driven by AI Fears and Trump's Iran Threats
- Market Volatility Drivers: The stock market experienced significant fluctuations on Tuesday, primarily due to heightened investor fears regarding artificial intelligence and threats from Trump concerning Iran, which led to a sharp decline in indices.
- Investor Sentiment Impact: The uncertainty surrounding future economic conditions has dampened investor sentiment, resulting in a rebound from lows but an overall weak trend, indicating a lack of confidence in economic recovery.
- Inflation Data Focus: The market is anticipating the upcoming Consumer Price Index (CPI) data release, with analysts widely expecting inflation to continue influencing monetary policy, potentially leading the Federal Reserve to adopt a more cautious stance.
- Future Outlook: Amid rapid advancements in AI technology, the market is filled with concerns regarding the prospects of related companies, prompting investors to closely monitor policy changes and global economic dynamics to adjust their investment strategies.
See More
Hinge Health Q2 2026 Revenue Forecast Exceeds Expectations
- Revenue Growth Outlook: Hinge Health expects Q2 2026 revenue between $200 million and $202 million, representing approximately 45% year-over-year growth at the midpoint, surpassing Wall Street's estimate of $194.95 million, indicating strong market demand and business expansion capabilities.
- Operating Income Forecast: The projected non-GAAP operating income for Q2 is between $50 million and $52 million, with a non-GAAP operating margin expected to be around 25% at the midpoint, reflecting effective strategies in cost control and profitability enhancement.
- Full-Year Performance Prediction: Hinge Health now anticipates full-year 2026 revenue between $818 million and $824 million, implying roughly 40% year-over-year growth at the midpoint, also exceeding the market estimate of $801.58 million, showcasing the company's sustained growth potential.
- Stock Price Reaction: Following the earnings forecast, Hinge Health shares rose 1.9% in after-hours trading, demonstrating investor confidence in the company's future growth prospects and a positive market response.
See More
